Cancer is one of the leading causes of death worldwide. Early cancer detection is critical
because it can significantly improve treatment outcomes, thus saving lives, reducing …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer with a high death
rate in the world. The molecular mechanisms related to the pathogenesis of HCC have not …

Background Patients with advanced hepatocellular carcinoma (aHCC) have a poor
prognosis and high mortality. Nivolumab monotherapy demonstrated clinical benefit with an …

Hepatocellular carcinoma (HCC) remains a global health challenge with high mortality rates,
largely due to late diagnosis and suboptimal efficacy of current therapies. With the …

Background Alpha-fetoprotein (AFP) is a fetal protein that can indicate congenital anomalies
such as Down syndrome and spinal canal blockage when detected at abnormal levels in …

Background and Objectives: Serum alpha-fetoprotein (AFP) is a recognized affordable
oncological marker in patients with hepatocellular carcinoma (HCC). However, AFP's …

Alpha-fetoprotein (AFP) is a glycoprotein primarily expressed during embryogenesis, with
declining levels postnatally. Elevated AFP levels correlate with pathological conditions such …

Background: The continuous increase in the incidence of HCC in China is an urgent issue,
and early diagnosis and treatment are crucial. This study aims to create personalized …